doi: 10.1016/j.cmet.2019.07.013 138 ZhangQDelessaCTAugustinRBakhtiMColldnGDruckerDJet al
Wellness clinics, telehealth providers, and independent consumers utilize the blend to accelerate deep tissue repair, modulate chronic systemic inflammation, stimulate profound collagen synthesis, and initiate systemic rejuvenation from the cellular level outward
Safety Profile: What Happens When Non-Diabetics Take GLP-1 Non-diabetic patients using GLP-1 medications experience a different safety profile than diabetic users because they don't face hypoglycemia (dangerous blood sugar drops)
The most commonly reported side effects include: Nausea : Affecting 12% to 24% of patients with type 2 diabetes and 24% to 31% in weight management trials [1] [14] Diarrhea : 12% to 17% in diabetes trials and 18% to 23% in weight management trials Decreased appetite : 5% to 10% of patients Vomiting : 5% to 10% in diabetes trials and 8% to 12% in weight management trials Constipation : 5% to 7% in diabetes trials and 16% to 17% in weight management trials Dyspepsia : 5% to 9% of patients Abdominal pain : 5% to 9% of patients Alopecia (hair loss) : Reported in weight management trials These symptoms are typically mild to moderate in severity, occur most commonly during dose escalation, and tend to diminish over time as patients develop tolerance
This article will explore whether you can take these three together, how they support one another, and why the delivery method you choose is the most important factor in seeing results
